Animal models of autoimmune hepatitis.
Animal models of autoimmune hepatitis have been important in defining pathogenic mechanisms, and they promise to aid in the evaluation of new molecular and cellular treatments. They have evolved from models based on crude liver homogenates that produced a transient hepatitis to models that express antibodies to human antigens, manifest liver-infiltrating T cells, persist for at least 3 months and develop fibrosis. Animal models allow the study of autoimmune hepatitis from its inception, and they can detail the progression of pathological events. Key imbalances in counter-regulatory mechanisms can be isolated and manipulated. Models can be humanized by the insertion of human genetic promoters and the expression of human antigens. Genetic engineering and preconditioning have been milestones in the evolution of animal models. Vaccination or infection of murine models with viral vectors carrying human antigens are the most recent developments. Animal models promise to extend the knowledge of etiological agents and improve treatment algorithms.
Czaja
Albert J
AJ
Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA. czaja.albert@mayo.edu
D000818:Animals; D000941:Antigens / Q000235:genetics; D004195:Disease Models, Animal; D018450:Disease Progression; D005818:Genetic Engineering; D005822:Genetic Vectors; D019693:Hepatitis, Autoimmune / Q000235:genetics / Q000276:immunology / Q000628:therapy; D006801:Humans; D015203:Reproducibility of Results; D013045:Species Specificity; D014611:Vaccination
D000941:Antigens